Clinical Trial Results:
A multi-centre, randomised, double-blind, double-dummy,
placebo-controlled, 3-way crossover, incomplete block design
study to investigate the efficacy, safety, tolerability,
pharmacodynamics and pharmacokinetics of three inhaled doses
of GSK233705 (10, 20 and 50mcg twice daily) administered
concurrently with salmeterol 50mcg twice daily, and salmeterol
50mcg twice daily alone, in subjects with chronic obstructive
pulmonary disease (COPD)
Summary
|
|
EudraCT number |
2006-003500-19 |
Trial protocol |
DE FI NL GB |
Global completion date |
31 May 2007
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
02 Jul 2016
|
First version publication date |
02 Jul 2016
|
Other versions |
|
Summary report(s) |
106956-Clinical-Study-Result-Summary |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.